| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.LTGMAFR.V 4.43 0.03 398.2150 58.80 - 66.66 2 8.5E5 62.00 227 233 N
R.GASQNIIPASTGAAK.A 4.71 3.28 693.3774 49.37 - 58.23 2 5.8E5 52.71 200 214 N
R.VPTPNVSVVDLTVR.L 3.08 3.93 748.4323 102.57 - 106.21 2 3.2E5 104.11 234 247 N
K.LVSWYDNEFGYSHR.V Y 3.34 4.55 591.6087 95.29 - 99.61 3 1.9E5 96.97 309 322 Y
R.VVISAPSADAPMFVMGVNHEK.Y Y 2.71 11.50 733.7071 108.20 - 112.60 3 1.6E5 110.20 118 138 Y
R.VPTPNVSVVDLTVR.L 2.09 3.14 499.2905 102.53 - 106.24 3 6.8E4 104.10 234 247 N
R.GASQNIIPASTGAAK.A 2.73 3.56 462.5874 49.16 - 58.26 3 6.4E4 52.70 200 214 N
K.GILGYTEDQVVSTDFNGDTR.S Y 1.02 0.90 729.6807 103.92 - 110.55 3 6.3E4 107.14 271 290 Y
K.LTGMAFR.V 2.86 0.29 795.4234 58.83 - 66.69 1 6.1E4 62.00 227 233 N
R.SSIFDAGAGIALNDHFVK.L 0.76 1.12 621.3191 117.15 - 123.45 3 5.2E4 118.83 291 308 N
K.YDSSMK.V Y 2.21 3.99 365.6597 27.64 - 31.26 2 4.8E4 29.08 139 144 N
F.RVPTPNVSVVDLTVR.L 1.67 1.63 551.3257 93.29 - 98.34 3 4.8E4 95.68 233 247 N
Y.DNEFGYSHR.V 2.53 1.73 562.7456 36.12 - 46.66 2 4.7E4 39.35 314 322 N
R.VCDLVLHMFSK.E Y 1.86 4.51 431.2248 118.50 - 122.42 3 4.1E4 120.25 323 333 N
K.L(+43.01)TGMAFR.V 2.10 4.12 419.7178 102.00 - 106.49 2 3.7E4 104.11 227 233 N Carbamylation
K.VVSNASCTTNCLAPVAK.V Y 1.21 12.14 839.4219 65.32 - 71.26 2 3.3E4 67.85 145 161 N
K.AAAEGPMK.G Y 1.15 0.28 774.3909 27.89 - 32.74 1 3.2E4 29.71 263 270 N
K.VVPELNGK.L Y 2.37 1.40 855.4982 41.97 - 51.34 1 3.1E4 45.40 219 226 N
K.GILGYTEDQVVSTDFNGDTR.S Y 1.87 2.77 1094.0180 105.98 - 109.74 2 3E4 107.59 271 290 N
Y.DNEFGYSHR.V 2.00 1.31 375.4984 36.15 - 46.17 3 2.9E4 39.88 314 322 N
K.LVSWYDNEFGYSHR.V Y 1.91 1.93 886.9091 95.08 - 99.28 2 2.8E4 96.93 309 322 N
K.YDSTHGVWK.L Y 1.05 0.78 546.7668 40.22 - 49.67 2 2.7E4 44.26 47 55 N
K.LTGMAFR.V 1.90 2.28 398.2181 49.85 - 58.63 2 2.6E4 53.17 227 233 N
R.VCDLVLHMFSK.E Y 1.33 2.10 646.3370 118.50 - 122.36 2 2.6E4 120.20 323 333 N
K.YDSTHGVWK.L Y 2.25 12.02 364.8438 40.22 - 47.21 3 2.6E4 43.79 47 55 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 0.72 2.55 589.5587 100.34 - 105.07 4 2.5E4 102.50 117 138 N
R.LEKPAKYDDIKK.V 1.06 0.65 483.2808 30.82 - 35.52 3 2.4E4 32.94 248 259 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 1.29 1.06 785.7413 99.64 - 105.40 3 2.3E4 102.24 117 138 N
R.VC(+57.02)DLVLHMFSK.E Y 1.50 1.64 450.2327 108.57 - 112.83 3 2.3E4 110.51 323 333 N Carbamidomethylation
R.V(+43.01)CDLVLHMFSK.E Y 1.67 2.52 445.5610 111.83 - 116.25 3 2.2E4 113.97 323 333 N Carbamylation
K.YDDIK.K 0.87 0.76 653.3239 29.40 - 34.98 1 2E4 31.42 254 258 N
K.IGINGFGR.I Y 0.00 5.14 417.2334 68.77 - 72.01 2 2E4 69.94 4 11 N
R.LEKPAKYDDIKK.V 0.25 0.44 362.7113 30.75 - 35.55 4 1.9E4 33.22 248 259 N
K.YDDIK.K 0.49 0.73 327.1616 29.66 - 31.53 2 1.6E4 30.56 254 258 N
Y.VVESTGVFTTIEK.A 1.12 1.32 705.3819 82.42 - 85.83 2 1.6E4 83.53 94 106 N
E.YMVYMFK.Y 0.84 0.16 491.2374 94.52 - 99.03 2 1.3E4 97.10 40 46 N
R.VVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.40 0.74 728.3619 107.41 - 110.39 4 1.3E4 108.62 118 144 N
R.VC(+57.02)DLVLHMFSK.E Y 0.90 1.17 674.8464 108.61 - 111.42 2 1.3E4 110.18 323 333 N Carbamidomethylation
K.V(+43.01)VSNASCTTNCLAPVAK.V Y 0.73 10.35 860.9263 62.80 - 68.66 2 1.2E4 64.95 145 161 N Carbamylation
N.VSVVDLTVR.L 1.76 1.37 494.2992 81.20 - 85.91 2 1.1E4 83.17 239 247 N
K.VVSNASCTTNCLAPVAK.V Y 0.12 6.00 559.9481 66.76 - 70.90 3 1.1E4 68.00 145 161 N
K.YDDIKK.V 0.06 1.48 391.2137 28.32 - 32.49 2 1E4 29.79 254 259 N
K.VVSNASCTTNCLAPVAK(+43.01).V Y 1.18 14.59 860.9272 60.89 - 64.26 2 1E4 62.86 145 161 N Carbamylation
R.VPTPNVSVVD(+21.98)LTVR.L 1.49 1.31 506.6171 102.53 - 106.08 3 9.6E3 104.03 234 247 N Sodium adduct
K.DPANIK.W 0.10 1.78 329.1826 28.44 - 34.17 2 9.4E3 30.63 80 85 N
R.VCDLVLHMF.S Y 1.72 1.26 538.7699 131.69 - 133.10 2 9.1E3 132.37 323 331 N
R.SSIFDAGAGIALNDHFVK.L 0.13 5.09 621.3224 117.72 - 122.59 3 8.1E3 119.97 291 308 N
K.L(+43.01)TGMAFR.V 0.56 0.61 838.4254 102.30 - 106.28 1 7.9E3 104.18 227 233 N Carbamylation
K.YDSTHGVWK.L Y 0.06 0.43 546.7602 40.64 - 46.32 2 7.8E3 43.68 47 55 N
K.VVNDNFVIVEGLMSTVH.A Y 1.20 2.15 624.9902 131.99 - 134.05 3 7.3E3 133.42 162 178 N
K.VVNDNFVIVEGLMSTVH.A Y 1.28 0.79 936.9839 132.09 - 134.23 2 6.9E3 133.59 162 178 N
K.RVVISAPSADAPMFVMGVNHEK.Y Y 0.28 3.79 785.7376 101.27 - 104.86 3 6.6E3 102.92 117 138 N
M.STVHAITATQK.T Y 0.42 0.85 578.8232 31.54 - 38.64 2 6.5E3 33.22 175 185 N
K.VVSNASC(+57.02)TTNCLAPVAK.V Y 0.70 2.63 867.9322 60.38 - 66.32 2 6.5E3 62.58 145 161 N Carbamidomethylation
M.VKIGINGFGR.I Y 1.24 0.61 354.2152 70.96 - 76.78 3 6.1E3 73.40 2 11 N
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 0.36 3.00 867.9331 57.71 - 63.55 2 5.8E3 59.81 145 161 N Carbamidomethylation
K.LTGMAFR.V 0.04 5.28 398.2065 59.66 - 63.44 2 5.5E3 61.34 227 233 N
R.SSIFDAGAGIALNDHFVK.L 0.32 0.07 931.4797 117.95 - 121.36 2 5.3E3 118.88 291 308 N
K.RVVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.09 5.86 767.3849 100.45 - 102.69 4 4.9E3 101.47 117 144 N
R.VC(+57.02)DLVLHMF.S Y 1.08 1.07 567.2822 128.79 - 130.26 2 4.8E3 129.52 323 331 N Carbamidomethylation
D.APMFVMGVNHEK.Y 0.64 0.50 453.8926 68.76 - 73.14 3 4.7E3 71.42 127 138 N
K.RVVISAPSADAPMFVMGVNHEKYDSSMK.V Y 0.12 5.91 614.1063 100.33 - 102.18 5 4.6E3 100.96 117 144 N
K.VVSNASC(+57.02)TTNC(+57.02)LAPVAK.V Y 0.26 1.50 896.4530 49.24 - 58.96 2 4.2E3 53.79 145 161 N Carbamidomethylation
R.LEKPAKYDDIKK.V 0.50 8.37 724.4232 31.34 - 35.41 2 4.2E3 33.52 248 259 N
R.L(+43.01)EKPAK.Y 0.23 0.93 364.7212 31.71 - 33.50 2 3.8E3 32.46 248 253 N Carbamylation
K.WGDAGADYVVESTGVFTTIEK.A Y 0.15 5.25 749.0335 128.85 - 132.32 3 3.6E3 130.54 86 106 N
R.V(+43.01)CDLVLHMF.S Y 0.79 1.87 560.2723 130.46 - 131.89 2 3.4E3 131.06 323 331 N Carbamylation
K.I(+43.01)GINGFGR.I Y 0.14 1.56 438.7446 92.90 - 95.72 2 3.2E3 94.33 4 11 N Carbamylation
R.SSIFDAGAGIALNDHFVK.L 0.10 0.29 931.4575 117.66 - 121.45 2 3.1E3 119.28 291 308 N
R.VCDLVLHMFSKE Y 0.88 3.57 474.2420 120.60 - 122.90 3 3E3 121.94 323 334 N
K.ADGGK.L 0.01 5.25 447.2176 62.82 - 67.53 1 2.8E3 65.55 61 65 N
R.LEKPAKYDDIK.K 0.30 7.20 660.3660 35.74 - 40.13 2 2.8E3 38.07 248 258 N
R.V(+43.01)C(+45.99)DLVLHMFSK.E Y 1.22 0.66 460.8896 114.56 - 117.20 3 2.7E3 116.17 323 333 N Carbamylation; Beta-methylthiolation
K.LVIGNMHITVFHEKDPANIK.W Y 0.19 6.22 569.8122 97.20 - 100.07 4 2.6E3 98.24 66 85 N
M.STVHAITATQK.T Y 0.05 0.25 386.2164 32.05 - 33.96 3 2.5E3 32.88 175 185 N
R.VC(+57.02)DLVLHMFSKE Y 0.13 0.24 493.2526 110.65 - 113.40 3 2.4E3 111.98 323 334 N Carbamidomethylation
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 0.05 5.28 578.9551 58.45 - 60.49 3 2.4E3 59.42 145 161 N Carbamidomethylation
R.V(+43.01)CDLVLHMFSK.E Y 0.02 5.38 667.8394 110.86 - 115.68 2 2.4E3 113.54 323 333 N Carbamylation
K.L(+43.01)VSWYDNEFGYSHR.V Y 0.24 2.58 908.4195 131.48 - 134.38 2 2.4E3 132.84 309 322 N Carbamylation
R.LEKPAKYDDIK.K 0.02 5.39 440.5830 36.56 - 40.37 3 2E3 38.42 248 258 N
K.LVIGNMHITVFHEKDPANIK.W Y 0.33 2.95 456.0536 97.10 - 99.04 5 1.7E3 97.97 66 85 N
R.V(+43.01)PTPNVSVVDLTVR.L 0.49 7.97 769.9343 123.13 - 124.83 2 1.6E3 124.11 234 247 N Carbamylation
K.VVSNASCTTNC(+57.02)LAPVAK.V Y 0.02 2.60 867.9376 59.32 - 62.02 2 1.2E3 60.39 145 161 N Carbamidomethylation
R.VVISAPSADAPMFVMGVNHEK.Y Y 0.21 6.05 550.5284 109.07 - 111.12 4 1.2E3 109.92 118 138 N
R.V(+43.01)CDLVLHMFSKE Y 0.23 7.17 488.5769 114.34 - 117.86 3 1.1E3 116.31 323 334 N Carbamylation
K.LVIGNMHITVFHEK.D Y 0.08 0.31 410.2237 100.45 - 102.52 4 808.1 101.35 66 79 N
K.L(+43.01)VSWYDNEFGYSHR.V Y 0.10 5.90 605.9418 132.44 - 134.48 3 581.8 133.24 309 322 N Carbamylation
total 87 peptides